FDA Approves Cosopt Pf (dorzolamide hydrochloride-timolol maleate ophthalmic solution) for reduction of elevated intraocular pressure in open-angle glaucoma or ocular hypertension.
The FDA approved a new preservative-free eye drop called Cosopt Pf for treating high eye pressure.
FDA approved Cosopt Pf, a preservative-free ophthalmic solution of dorzolamide hydrochloride and timolol maleate, for reducing elevated intr…
FDA approves new preservative-free eye drop for high eye pressure in patients who don't respond well to beta-blockers.
Meta-analysis finds contralateral IOP reduction after unilateral selective laser trabeculoplasty
Unilateral SLT treatment linked to lower pressure in the other eye
A systematic review and meta-analysis of 9 studies (478 eyes) in POAG and OHT patients found unilateral SLT was associated with a mean contr…
Treating one eye with laser therapy lowers pressure in the other eye by an average of 1.85 mmHg without reported safety concerns.
Microdrop device reduces bottle exhaustion and adverse events in glaucoma patients on monotherapy
Small study finds microdrop device may lower eye pressure and reduce medication waste in glaucoma
A prospective randomized crossover trial in 29 adults with stable glaucoma or ocular hypertension on monotherapy found microdrops decreased …
A new device lowers eye pressure better than standard drops and cuts waste, stopping 83% of users from running out of medication early.